| Randomized Double Blinding Controlled Study on" Jia Wei Xiao Yao Jiaonang" Treating Mild to Moderate Major Depressive Disorder (NCT01467804) | Su Rui | 2011-11-01 |
| Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial) (NCT01360866) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-10-01 |
| Buprenorphine for Treatment Resistant Depression (NCT01407575) | University of Pittsburgh | 2011-09-01 |
| Bupropion & Cardio Birth Defect (Slone) (NCT01597661) | GlaxoSmithKline | 2011-09-01 |
| Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial) (NCT01360645) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-07-01 |
| Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) (NCT01360632) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-06-01 |
| Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence (NCT01528748) | University of Virginia | 2011-04-01 |
| Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions (NCT01307475) | Freeman-Sheldon Research Group, Inc. | 2011-02-01 |
| Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging (NCT01831440) | Nanjing Medical University | 2011-01-01 |
| Escitalopram and Depression in Elderly Alzheimer's Patients (NCT00488670) | University of British Columbia | 2010-12-01 |
| Project SERVE: Post Deployment Functioning (NCT01123642) | VA Office of Research and Development | 2010-10-01 |
| Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations (NCT01093053) | The Center for Mind-Body Medicine | 2010-09-01 |
| Psychosocial Issues and Bariatric Surgery (NCT02495142) | Neuropsychiatric Research Institute, Fargo, North Dakota | 2010-07-01 |
| Bupropion and Specific Cardiovascular Malformations (NCT01165255) | GlaxoSmithKline | 2010-06-01 |
| Nonconvulsive Electrotherapy: a Proof-of-concept Trial (NCT01065597) | University of Maryland, College Park | 2010-05-01 |
| Study of the Telomere-telomerase System and the Expression of Candidate Genes in the Leukocytes of Patients With Depressive Disorder: Search for Peripheral Markers of Somatic Stress (NCT01903655) | Centre Hospitalier Universitaire Dijon | 2010-04-01 |
| Somatic Disease Among Alcohol Abusers in an Out-day Patients' Clinic (NCT01081197) | Helse Nord-Trøndelag HF | 2010-03-01 |
| Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders (NCT01643642) | Leiden University Medical Center | 2010-03-01 |
| A PET Study in Healthy Volunteers (NCT01424449) | GlaxoSmithKline | 2010-01-01 |
| Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions (NCT01046214) | Teva Pharmaceuticals USA | 2010-01-01 |
| Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects (NCT01000857) | GlaxoSmithKline | 2009-11-05 |
| Depression Attention for Women Now (The DAWN Study) (NCT01096316) | University of Washington | 2009-11-01 |
| Paxil CR Bioequivalence Study Brazil - Fed Administration (NCT01339247) | GlaxoSmithKline | 2009-10-20 |
| Paxil CR Bioequivalence Study Brazil (NCT01316926) | GlaxoSmithKline | 2009-09-09 |
| Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression (NCT01829100) | Rutgers University | 2009-09-01 |
| Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects (NCT00938184) | GlaxoSmithKline | 2009-07-14 |
| Insulin Resistance in Patients With Major Depression (NCT01106313) | Stanford University | 2009-07-01 |
| Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders (NCT01117753) | Medical University of South Carolina | 2009-07-01 |
| Safety and Efficacy Study in Patients With Major Depressive Disorder (NCT00896363) | GlaxoSmithKline | 2009-04-23 |
| An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands (NCT01153802) | GlaxoSmithKline | 2009-04-03 |
| Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study) (NCT00866294) | GlaxoSmithKline | 2009-04-01 |
| A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder (NCT00880048) | GlaxoSmithKline | 2009-03-11 |
| Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study) (NCT00812812) | GlaxoSmithKline | 2009-03-01 |
| Functional MRI Before and After Treatment for Depression (NCT00896441) | Stanford University | 2009-02-01 |
| Primary Care Patients With Depression for Internet-Based Social Support (NCT00886730) | University of Chicago | 2008-10-01 |
| Food and Relative Bioavailability Study (NCT00843011) | GlaxoSmithKline | 2008-08-28 |
| GSK372475 PK Study in Healthy Volunteers (NCT00728208) | GlaxoSmithKline | 2008-07-28 |
| PAXIL CR Bioequivalence Study (NCT00749359) | GlaxoSmithKline | 2008-07-07 |
| Carcinogenicity Study of Bupropion (NCT01077596) | GlaxoSmithKline | 2008-06-01 |
| Increasing Cost-effectiveness of Inpatient Treatment of Affective Disorders (NCT00662428) | University Hospital Freiburg | 2008-05-01 |
| Prevention of Adolescent Major Depression (NCT00611052) | Finnish Institute for Health and Welfare | 2008-03-01 |
| Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients (NCT00655226) | Icahn School of Medicine at Mount Sinai | 2008-03-01 |
| The Antidepressant Effect of Right Temporal Low Frequency rTMS Compared to Sham (NCT00622947) | University of Aarhus | 2008-02-01 |
| An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients (NCT00520507) | Queen's University | 2007-10-01 |
| Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients (NCT00525928) | Butler Hospital | 2007-10-01 |
| Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers (NCT00525837) | Butler Hospital | 2007-09-01 |
| Detection and Treatment of Depression in Patients Admitted to the General Hospital (NCT00521911) | Radboud University Medical Center | 2007-08-01 |
| GSK372475 Bioequivalence Study (NCT00488098) | GlaxoSmithKline | 2007-07-01 |
| The Effect of Duloxetine on Interoceptive Awareness (NCT00337012) | University Hospital, Bonn | 2007-07-01 |
| 28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296) (NCT00511654) | GlaxoSmithKline | 2007-06-12 |
| Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome (NCT00419471) | Chonnam National University Hospital | 2007-05-01 |
| A Study Of New Medicine (GSK 372475) For The Treatment Of Depression (NCT00448058) | GlaxoSmithKline | 2007-04-01 |
| A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure (NCT00439868) | GlaxoSmithKline | 2007-02-16 |
| A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression (NCT00429260) | Sanofi | 2007-01-01 |
| MDD POC Study GSK372475 Subjects Depressive Disease (NCT00420641) | GlaxoSmithKline | 2006-12-19 |
| An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder (NCT00415142) | Sanofi | 2006-12-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women (NCT00406640) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| Multifaceted Depression and Cardiovascular Program (NCT02069912) | University of Southern California | 2006-11-01 |
| Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder (NCT00380042) | Northstar Neuroscience | 2006-09-01 |
| Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects (NCT00366652) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women (NCT00369343) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure (NCT00437827) | MYnd Analytics | 2006-08-01 |
| An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder (NCT00361491) | Sanofi | 2006-08-01 |
| An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder (NCT00358631) | Sanofi | 2006-07-01 |
| Group Therapy for Women Prisoners With Comorbid Substance Use and Depression (NCT00606996) | Brown University | 2006-07-01 |
| The ACHIEVA Study of Enhanced Pharmacist Care on Antidepressant Use and Response (NCT00356655) | University of Alberta | 2006-07-01 |
| Memantine Augmentation of Antidepressants (NCT00344682) | University of Massachusetts, Worcester | 2006-06-01 |
| A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects (NCT00406432) | GlaxoSmithKline | 2006-05-09 |
| A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder (NCT00345098) | Sanofi | 2006-05-01 |
| An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression (NCT00319709) | Sanofi | 2006-04-01 |
| Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects (NCT00406003) | GlaxoSmithKline | 2006-03-24 |
| Telephone Administered Psychotherapy for the Treatment of Depression for Veterans in Rural Areas (NCT00223652) | US Department of Veterans Affairs | 2006-03-01 |
| Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors (NCT00296517) | GlaxoSmithKline | 2006-01-19 |
| Mild Depression 2 Week Observational Study (NCT00285831) | Stanford University | 2005-12-01 |
| Early Integrated Intervention in Severe Affective Disorders (NCT00253071) | Hovedstadens Sygehusfaelesskab | 2005-12-01 |
| Beyond Ageing Project: A Study for the Prevention of Depression (NCT00214682) | Australian National University | 2005-10-01 |
| GW679769 In Fibromyalgia (NCT00264628) | GlaxoSmithKline | 2005-10-01 |
| Treatment of Psychotic Major Depression With Mifepristone (NCT00867360) | Stanford University | 2005-08-01 |
| Effects of Psychoeducation of Relatives to Patients With Serious Mental Illness (NCT00184379) | Norwegian University of Science and Technology | 2005-04-01 |
| An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression (NCT00250601) | Sanofi | 2005-04-01 |
| Efficacy Study of a Computer Decision Support System to Treat Depression (NCT00551083) | University of Texas Southwestern Medical Center | 2005-03-01 |
| The Immune System and Psychiatric Disorders (NCT00184418) | Norwegian University of Science and Technology | 2005-01-01 |
| Study Of 323U66 SR In Major Depressive Disorder (NCT00135512) | GlaxoSmithKline | 2004-12-01 |
| An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression (NCT00250627) | Sanofi | 2004-12-01 |
| An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression (NCT00256113) | Sanofi | 2004-12-01 |
| A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder (NCT00191061) | Eli Lilly and Company | 2004-10-01 |
| Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders (NCT00438685) | Medical University of South Carolina | 2004-10-01 |
| Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease (NCT00304161) | University of Pennsylvania | 2004-07-01 |
| Electroacupuncture for Major Depression (NCT00071110) | National Center for Complementary and Integrative Health (NCCIH) | 2004-03-01 |
| Genetics of Symptomatology and Treatment Response in Psychotic Major Depression (NCT00691535) | Stanford University | 2003-10-01 |
| Seasonal Affective Depression (SAD) Study (NCT00069459) | GlaxoSmithKline | 2003-09-23 |
| An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression (NCT00070694) | National Institute of Mental Health (NIMH) | 2003-09-01 |
| Research Evaluating the Value of Augmenting Medication With Psychotherapy (NCT00057551) | Weill Medical College of Cornell University | 2003-04-01 |
| Effects of Therapist Behavior on the Treatment of Depressed Adolescents (NCT00073359) | University of Denver | 2003-02-01 |
| Nicotinic Receptor Augmentation of SSRI Antidepressants (NCT00319319) | Yale University | 2003-01-01 |
| The Effect of Testosterone on Mood and Quality of Life (NCT00202462) | Seattle Institute for Biomedical and Clinical Research | 2002-11-01 |
| A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression (NCT00044681) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-10-01 |
| Improving Retention of Hispanics Receiving Antidepressant Therapy (NCT00057642) | New York State Psychiatric Institute | 2002-09-01 |
| The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECT (NCT00299403) | University of Aarhus | 2002-05-01 |
| Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder (NCT00036309) | Eli Lilly and Company | 2002-05-01 |